ProRx LLC 2024-09-11 Health serious FDA
Health · FDA · Recall #FDA-D-0651-2024
Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx… Recall
Issued September 11, 2024 · ProRx LLC
In September 2024, ProRx LLC recalled the Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ProRx LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ProRx LLC
- Category
- Health
- Recall date
- September 11, 2024
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0651-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- ProRx LLC has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.